Black Rock Inc. Neogenomics Inc Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, Black Rock Inc. holds 19,670,074 shares of NEO stock, worth $353 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
19,670,074
Previous 19,850,864
0.91%
Holding current value
$353 Million
Previous $312 Million
12.57%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding NEO
# of Institutions
295Shares Held
125MCall Options Held
698KPut Options Held
120K-
Vanguard Group Inc Valley Forge, PA14MShares$252 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$124 Million0.13% of portfolio
-
Janus Henderson Group PLC London, X06.6MShares$119 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.54MShares$118 Million0.06% of portfolio
-
State Street Corp Boston, MA4.96MShares$89.1 Million0.0% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $2.26B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...